AU2002367943A1 - Improved reagents and methods for producing parvoviruses - Google Patents

Improved reagents and methods for producing parvoviruses

Info

Publication number
AU2002367943A1
AU2002367943A1 AU2002367943A AU2002367943A AU2002367943A1 AU 2002367943 A1 AU2002367943 A1 AU 2002367943A1 AU 2002367943 A AU2002367943 A AU 2002367943A AU 2002367943 A AU2002367943 A AU 2002367943A AU 2002367943 A1 AU2002367943 A1 AU 2002367943A1
Authority
AU
Australia
Prior art keywords
parvoviruses
producing
methods
improved reagents
reagents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002367943A
Other versions
AU2002367943A8 (en
Inventor
Joseph E. Rabinowitz
Richard Jude Samulski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of North Carolina at Chapel Hill
Original Assignee
University of North Carolina at Chapel Hill
University of North Carolina System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of North Carolina at Chapel Hill, University of North Carolina System filed Critical University of North Carolina at Chapel Hill
Publication of AU2002367943A8 publication Critical patent/AU2002367943A8/en
Publication of AU2002367943A1 publication Critical patent/AU2002367943A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
AU2002367943A 2001-12-18 2002-12-02 Improved reagents and methods for producing parvoviruses Abandoned AU2002367943A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34191901P 2001-12-18 2001-12-18
US60/341,919 2001-12-18
PCT/US2002/038423 WO2003104392A2 (en) 2001-12-18 2002-12-02 Improved reagents and methods for producing parvoviruses

Publications (2)

Publication Number Publication Date
AU2002367943A8 AU2002367943A8 (en) 2003-12-22
AU2002367943A1 true AU2002367943A1 (en) 2003-12-22

Family

ID=29735975

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002367943A Abandoned AU2002367943A1 (en) 2001-12-18 2002-12-02 Improved reagents and methods for producing parvoviruses

Country Status (2)

Country Link
AU (1) AU2002367943A1 (en)
WO (1) WO2003104392A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8241622B2 (en) 2001-07-13 2012-08-14 University Of Iowa Research Foundation Adeno-associated virus vectors with intravector heterologous terminal palindromic sequences
NZ532635A (en) 2001-11-13 2007-05-31 Univ Pennsylvania A method of identifying unknown adeno-associated virus (AAV) sequences and a kit for the method
EP1453547B1 (en) 2001-12-17 2016-09-21 The Trustees Of The University Of Pennsylvania Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor
DK3116900T3 (en) 2014-03-09 2020-09-28 Univ Pennsylvania COMPOSITIONS THAT CAN BE USED TO TREAT ORNITHIN TRANSCARBAMYLASE (OTC) DEFECT
WO2017139381A1 (en) 2016-02-08 2017-08-17 University Of Iowa Research Foundation Methods to produce chimeric adeno-associated virus/bocavirus parvovirus
EA201892006A1 (en) 2016-03-07 2019-04-30 Юниверсити Оф Айова Рисерч Фаундейшн AAV-MEDIATED EXPRESSION USING THE SYNTHETIC PROMOTER AND ENCHANSER
EP3456822A1 (en) * 2017-09-19 2019-03-20 CEVEC Pharmaceuticals GmbH Inducible aav rep genes
CN112166195A (en) 2018-03-06 2021-01-01 佛罗里达大学研究基金会有限公司 AAV chimeras
CN108465107B (en) * 2018-06-05 2020-02-21 山东信得科技股份有限公司 Duck type 2 adenovirus and Muscovy duck parvovirus disease combined inactivated vaccine
US10557149B1 (en) * 2019-07-15 2020-02-11 Vigene Biosciences, Inc. Recombinantly-modified adeno-associated virus helper vectors and their use to improve the packaging efficiency of recombinantly-modified adeno-associated virus
WO2023220043A1 (en) * 2022-05-09 2023-11-16 Synteny Therapeutics, Inc. Erythroparvovirus with a modified genome for gene therapy
WO2023220035A1 (en) * 2022-05-09 2023-11-16 Synteny Therapeutics, Inc. Erythroparvovirus compositions and methods for gene therapy

Also Published As

Publication number Publication date
AU2002367943A8 (en) 2003-12-22
WO2003104392A9 (en) 2004-04-29
WO2003104392A2 (en) 2003-12-18
WO2003104392A3 (en) 2004-08-05

Similar Documents

Publication Publication Date Title
AU785425C (en) Methods of genomic analysis
AU2002256895A1 (en) Anti-TRAIL-R antibodies
AU2002308751A1 (en) Authentication method
AU2002242683A1 (en) Method for producing 1-octen
EP1469316A2 (en) Screening method
AU2002367943A1 (en) Improved reagents and methods for producing parvoviruses
AU2002339707A1 (en) Genetic screening methods
AU2002300995A1 (en) Nickel Refining Method
AU2002249467A1 (en) Screening method
AU2002341150A1 (en) Method
AU2002365372A1 (en) New process
AU2002358637A1 (en) Method for producing deoxybenzoins
AUPR633101A0 (en) Method
AUPR573601A0 (en) Novel process
AU2002345028A1 (en) Authentication method
AU2002354247A1 (en) Screening method
AU2002328676A1 (en) Prognostic method
AU2000224577A1 (en) Screening method
AU2002220868A1 (en) Screening method
AU2001288116A1 (en) Screening method
AU2002339280A1 (en) Methods and reagents for peptide-bir interaction screens
AU2002232161A1 (en) Novel assay method
AU2002304420A1 (en) Novel method
AU2002317331A1 (en) Protein modification reagents
AU2002225421A1 (en) Novel screening method

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase